50 Views | 31 Downloads
Correspondence: Matthew C. Freeman, Email: matthew.freeman@emory.edu, https://www.FreemanResearchGroup.org.
Author contributions: CE, KAH, AE, SD, MCF, MS, WK, AB, and RAB: project conceptualization and methodology; KAH, KR, EAO, CC, MCF, WK, MS, and RAB: investigation and data curation; CE, EAO, KAH, KR, ZS, CJ, CY, MCF, and RAB: formal analysis; EAO, ZS, KAH, KR, AE, CJ, and CY: writing — original; EAO, CE, ZS, KAH, KR, AE, CY, CC, AB, MCF, and RAB: writing — review and editing; all authors provided approval of the submitted version.
Acknowledgements: We thank the Center for Molecular Dynamics, Nepal (CMDN), the Institut de Recherche en Santé de Surveillance Epidemiologique et de Formation (IRESSEF) in Dakar, Senegal, and the Center for Family Health Research in Zambia for their partnership in this study. We gratefully acknowledge the participants who gave their time and insights to help us better understand Nepal’s, Senegal’s, and Zambia’s vaccine delivery system, along with facilitators from the Ministry of Health and Population, Department of Health Services, and the Family Welfare Division of Nepal, Ministry of Health and Social Action in Senegal, and the Ministry of Health in Zambia for supporting this research. In addition, we thank Sarah Chesemore, Anna Rapp, Tove Ryman, and Ethan Wong from the Bill and Melinda Gates Foundation; Kate Buellesbach, Nancy Fullman, Nathaniel Gerthe, Gloria Ikilezi, Caitlyn Mason, David Phillips, and Oliver Rothschild, Jordan-Tate Thomas, and Angela Wang from Gates Ventures for technical support; and the Vaccine Exemplars Research Advisory Group for their insights, specifically Agnes Binagwaho, Laura Craw, Carolina Danovaro, Anuradha Gupta, Heidi Larson, Penelope Masumbu, Kate O’Brien, Helen Rees, Lora Shimp, and Aaron Wallace.
Competing interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
This work was supported by the Bill & Melinda Gates Foundation, Seattle, WA (OPP1195041) with a planning grant from Gates Ventures, LLC, Kirkland, WA.
© The Author(s) 2023